Literature DB >> 25727508

Status epilepticus and refractory status epilepticus management.

Nicholas S Abend1, David Bearden2, Ingo Helbig2, Jennifer McGuire2, Sona Narula2, Jessica A Panzer2, Alexis Topjian3, Dennis J Dlugos2.   

Abstract

Status epilepticus (SE) describes persistent or recurring seizures without a return to baseline mental status and is a common neurologic emergency. SE can occur in the context of epilepsy or may be symptomatic of a wide range of underlying etiologies. The clinician's aim is to rapidly institute care that simultaneously stabilizes the patient medically, identifies and manages any precipitant conditions, and terminates seizures. Seizure management involves "emergent" treatment with benzodiazepines followed by "urgent" therapy with other antiseizure medications. If seizures persist, then refractory SE is diagnosed and management options include additional antiseizure medications or infusions of midazolam or pentobarbital. This article reviews the management of pediatric SE and refractory SE.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25727508      PMCID: PMC4346709          DOI: 10.1016/j.spen.2014.12.006

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   3.042


  130 in total

1.  How long do new-onset seizures in children last?

Authors:  S Shinnar; A T Berg; S L Moshe; R Shinnar
Journal:  Ann Neurol       Date:  2001-05       Impact factor: 10.422

Review 2.  Super-refractory status epilepticus: an approach to therapy in this difficult clinical situation.

Authors:  Simon Shorvon
Journal:  Epilepsia       Date:  2011-10       Impact factor: 5.864

Review 3.  Pediatric intensive care treatment of uncontrolled status epilepticus.

Authors:  Ryan Wilkes; Robert C Tasker
Journal:  Crit Care Clin       Date:  2013-01-03       Impact factor: 3.598

Review 4.  Dravet syndrome (severe myoclonic epilepsy in infancy).

Authors:  Charlotte Dravet; Hirokazu Oguni
Journal:  Handb Clin Neurol       Date:  2013

5.  Autoantibodies to neuronal antigens in children with new-onset seizures classified according to the revised ILAE organization of seizures and epilepsies.

Authors:  Jehan Suleiman; Sukhvir Wright; Deepak Gill; Fabienne Brilot; Patrick Waters; Ken Peacock; Peter Procopis; Anjan Nibber; Angela Vincent; Russell C Dale; Bethan Lang
Journal:  Epilepsia       Date:  2013-10-23       Impact factor: 5.864

6.  Eight-year study of childhood status epilepticus: midazolam infusion in management and outcome.

Authors:  Roshan Koul; Alexander Chacko; Hashim Javed; Kassim Al Riyami
Journal:  J Child Neurol       Date:  2002-12       Impact factor: 1.987

7.  Five cases of new onset refractory status epilepticus (NORSE) syndrome: outcomes with early immunotherapy.

Authors:  Claire R E Gall; Odai Jumma; Rajiv Mohanraj
Journal:  Seizure       Date:  2013-01-18       Impact factor: 3.184

8.  Aborted and refractory status epilepticus in children: a comparative analysis.

Authors:  Florise A C P Lambrechtsen; Jeffrey R Buchhalter
Journal:  Epilepsia       Date:  2007-12-18       Impact factor: 5.864

9.  Cryptogenic New Onset Refractory Status Epilepticus (NORSE) in adults-Infectious or not?

Authors:  Daniel J Costello; Ronan D Kilbride; Andrew J Cole
Journal:  J Neurol Sci       Date:  2008-11-17       Impact factor: 3.181

10.  An epidemiological study of children with status epilepticus in Okayama, Japan.

Authors:  Itsuko Nishiyama; Yoko Ohtsuka; Toshihide Tsuda; Hideo Inoue; Taiji Kunitomi; Hiroshi Shiraga; Takafumi Kimura; Kiyoshi Fujimoto
Journal:  Epilepsia       Date:  2007-04-18       Impact factor: 5.864

View more
  8 in total

1.  Less Effective and More Expensive: Is It Time to Move on From Rectal Diazepam?

Authors:  Katherine C Nickels
Journal:  Epilepsy Curr       Date:  2018 Jan-Feb       Impact factor: 7.500

Review 2.  Emerging roles of Na⁺/H⁺ exchangers in epilepsy and developmental brain disorders.

Authors:  Hanshu Zhao; Karen E Carney; Lindsay Falgoust; Jullie W Pan; Dandan Sun; Zhongling Zhang
Journal:  Prog Neurobiol       Date:  2016-03-08       Impact factor: 11.685

Review 3.  Pharmacotherapy for Nonconvulsive Seizures and Nonconvulsive Status Epilepticus.

Authors:  Pablo Bravo; Aparna Vaddiparti; Lawrence J Hirsch
Journal:  Drugs       Date:  2021-04-08       Impact factor: 9.546

Review 4.  Emergency management of the paediatric patient with convulsive status epilepticus.

Authors:  Kyle C McKenzie; Cecil D Hahn; Jeremy N Friedman
Journal:  Paediatr Child Health       Date:  2021-01-21       Impact factor: 2.253

Review 5.  Management of Status Epilepticus in Children.

Authors:  Douglas M Smith; Emily L McGinnis; Diana J Walleigh; Nicholas S Abend
Journal:  J Clin Med       Date:  2016-04-13       Impact factor: 4.241

6.  Antagomir-mediated suppression of microRNA-134 reduces kainic acid-induced seizures in immature mice.

Authors:  Aoife Campbell; Gareth Morris; Janosch P Heller; Elena Langa; Elizabeth Brindley; Jesper Worm; Mads Aaboe Jensen; Meghan T Miller; David C Henshall; Cristina R Reschke
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

Review 7.  Treatment of Established Status Epilepticus.

Authors:  Jessica J Falco-Walter; Thomas Bleck
Journal:  J Clin Med       Date:  2016-04-25       Impact factor: 4.241

8.  Sodium valproate compared to phenytoin in treatment of status epilepticus.

Authors:  Mohammad Reza Amiri-Nikpour; Surena Nazarbaghi; Parisa Eftekhari; Sedra Mohammadi; Sina Dindarian; Mahdi Bagheri; Hozan Mohammadi
Journal:  Brain Behav       Date:  2018-03-23       Impact factor: 2.708

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.